recombinant human bmp2 protein r d systems (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
recombinant human bmp2 protein r d systems
Recombinant Human Bmp2 Protein R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 224 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+bmp+2/Recombinant+Human+BMP-2+GMP+Protein%2C+CF/pm41932341-856-64-68
Average 95 stars, based on 224 article reviews
Recombinant Human Bmp2 Protein R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 224 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+bmp+2/Recombinant+Human+BMP-2+GMP+Protein%2C+CF/pm41932341-856-64-68
Average 95 stars, based on 224 article reviews
recombinant human bmp2 protein r d systems - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Recombinant:Article Title: Automated Seamless Poly(ε-Caprolactone) Electrospun Tubes for Critically-Sized Bone Defect Repair. Article Snippet: In this study, we demonstrate an automated approach to efficiently and reproducibly manufacture perforated poly(e-caprolactone) (PCL) solution electrospun tubular meshes designed for critically-sized bone defect repair.. The workflow improves reproducibility and reduces fabrication time by 67% (8.7 vs. 2.7 h per 10 meshes).. By directly electrospinning PCL onto a rotating cylindrical mandrel, seam-related discontinuities are eliminated, and subsequent use of an automated soldering iron system enables precise 1 mm perforations that promote vascular ingrowth during bone healing. Article Title: Sequential Dual-Biofactor Release from the Scaffold of Mesoporous HA Microspheres and PLGA Matrix for Boosting Endogenous Bone Regeneration. Article Snippet: The combined design of scaffold structure and multi-biological factors is a prominent strategy to promote bone regeneration.. Herein, a composite scaffold of mesoporous hydroxyapatite (HA) microspheres loaded with the bone morphogenetic protein-2 (BMP-2) and a poly(DL-lactic-co-glycolic acid) (PLGA) matrix is constructed by 3D printing.. Furthermore, the chemokine stromal cell-derived factor-1α (SDF-1α) is adsorbed on a scaffold surface to achieve the sequential release of the dual-biofactors. Article Title: Small organic molecules for use in the treatment of neuroinflammatory disorders Article Snippet: An assay medium containing DMEM/F12, 2% FBS, 100 units/ml penicillin, 100 mg/ml streptomycin (Biological industries) was added to each well. .. Article Title: Human primordial germ cell-like cells specified from resetting precursors develop in human hindgut organoids. Article Snippet: • Irradiated Cf1 mouse embryonic fibroblasts (MEFs; Thermo Scientific, cat. no. A34180; RRID: CVCL_RB05) ▲ CAutIon MEFs used in the applications of this protocol should be regularly checked to ensure that they are authentic and are not infected with mycoplasma. .. • PBS without MgCl2 and CaCl2, pH 7.4 (1× PBS; Thermo Fisher Scientific, cat. no. 10010056) • Tryple Express Enzyme (1×), no phenol red (Fisher Scientific, cat. no. 12-604-013) • Vitronectin (VTN-N) recombinant human protein, truncated (vitronectin; Thermo Scientific, cat. no. A14700) • Gelatin from porcine skin (gelatin; Sigma-Aldrich, cat. no. G1890) • DMEM/F-12, no glutamine (Thermo Scientific, cat. no. 21331020) • Essential 8 (E8) medium (Thermo Scientific, cat. no. A1517001) • FBS (Sigma-Aldrich, cat. no. F7524 or cat. no. F2442) • Rock inhibitor Y-27632 (ROCKi; Tocris, cat. no. 1254) • ACCUTASE (STEMCELL Technologies, cat. no. 07920) • EDTA (Thermo Fisher Scientific, cat. no. 15575020) • Trypsin-EDTA (0.25% (wt/vol)), phenol red (Thermo Fisher Scientific, cat. no. 25-200-056) Article Title: PBVHx-based microspheres for controlled BMP2 release and enhanced bone regeneration in a disuse osteoporosis mouse model Article Snippet: .. Article Title: Moderate-Affinity Affibodies Modulate the Delivery and Bioactivity of Bone Morphogenetic Protein-2. Article Snippet: .. Sterile carrier-free Article Title: The Biphasic Activity of Auricularia Auricula-Judae Extract on Bone Homeostasis through Inhibition of Osteoclastogenesis and Modulation of Osteogenic Activity Article Snippet: .. Article Title: Moderate-Affinity Affibodies Modulate the Delivery and Bioactivity of Bone Morphogenetic Protein-2. Article Snippet: .. Protein Modifications: Enzyme-linked Immunosorbent Assay:Article Title: Sequential Dual-Biofactor Release from the Scaffold of Mesoporous HA Microspheres and PLGA Matrix for Boosting Endogenous Bone Regeneration. Article Snippet: The combined design of scaffold structure and multi-biological factors is a prominent strategy to promote bone regeneration.. Herein, a composite scaffold of mesoporous hydroxyapatite (HA) microspheres loaded with the bone morphogenetic protein-2 (BMP-2) and a poly(DL-lactic-co-glycolic acid) (PLGA) matrix is constructed by 3D printing.. Furthermore, the chemokine stromal cell-derived factor-1α (SDF-1α) is adsorbed on a scaffold surface to achieve the sequential release of the dual-biofactors. Concentration Assay:Article Title: Small organic molecules for use in the treatment of neuroinflammatory disorders Article Snippet: An assay medium containing DMEM/F12, 2% FBS, 100 units/ml penicillin, 100 mg/ml streptomycin (Biological industries) was added to each well. .. Sterility:Article Title: Moderate-Affinity Affibodies Modulate the Delivery and Bioactivity of Bone Morphogenetic Protein-2. Article Snippet: .. Sterile carrier-free Saline:Article Title: The Biphasic Activity of Auricularia Auricula-Judae Extract on Bone Homeostasis through Inhibition of Osteoclastogenesis and Modulation of Osteogenic Activity Article Snippet: .. |
![Comparative effects of BMP9 and <t>BMP2</t> on osteogenic differentiation and osteoclastogenesis in vitro. (A) Real‐time PCR analysis of key osteogenic genes (Col1, Runx2, ALP, and OCN) in MC3T3‐E1 cells treated with 8 nM of BMP2 or BMP9 for 3, 5, and 7 days. All gene‐expression levels were normalized to GAPDH. (B) Western blot analysis of osteogenic marker proteins in cell lysates harvested after 7 days of treatment with BMP2 or BMP9. GAPDH was used as the loading control. Densitometric quantification of band intensities (integrated density) normalized to GAPDH is shown below the blots and presented as relative protein expression. (C) Western blot showing dose‐dependent p‐Smad1/5/9 in MC3T3‐E1 cells exposed to varying concentrations of BMP2 or BMP9. Phosphorylation was quantified by densitometry and expressed as fold change vs. control after normalization using [(p‐Smad1/5/9)/(total Smad1/5/9)] and further normalized to GAPDH, as shown in the graph below the blots. Asterisks indicate statistical significance for pairwise comparisons between BMP2 and BMP9 at the same concentration (****, p < 0.0001), unless otherwise indicated. (D) ALP activity and representative images of ALP staining in MC3T3‐E1 cultures after 7 days of induction with BMP2 or BMP9. (E) Alizarin Red S staining illustrating mineralized nodule formation after extended culture with BMP2 or BMP9. (F) Representative TRAP‐stained images of RAW 264.7‐derived osteoclasts following treatment with RANKL (3 nM), BMP2 (8 nM), or BMP9 (8 nM) for 5 days. TRAP‐positive multinucleated osteoclasts are indicated by arrows. Scale bar, 20 μm. (G) Quantification of TRAP‐positive multinucleated cells per well. Data are presented as the mean ± SD ( n = 3 independent experiments), and p ‐values were calculated using one‐way analysis of variance (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). BMP, bone morphogenetic protein; PCR, polymerase chain reaction; ALP, alkaline phosphatase; Col1, collagen type I; Runx2, runt‐related transcription factor 2; OCN, osteocalcin; GAPDH, glyceraldehyde‐3‐phosphate dehydrogenase.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_4554/pmc12974554/pmc12974554__CID-28-0-g002.jpg)
